WebNov 17, 2024 · EaseVRx was given a Breakthrough Device Designation by the FDA in 2024 for treating fibromyalgia and chronic lower back pain. The designation speeds up the development and review of new medical devices. Marketing approval of EaseVRx – known as a "De Novo pre-market review" – creates a new regulatory classification for VR … WebFeb 24, 2024 · Digital health startup AppliedVR shared results from a pivotal study of its platform for lower back pain relief. The company plans to submit the results to the FDA in the next year. AppliedVR’s ...
FDA approves virtual reality system to ease back pain - UPI
WebOct 21, 2024 · EaseVRx is now one of the first virtual reality (VR) digital therapeutics to get breakthrough designation to treat conditions related to chronic pain. The FDA … WebOct 25, 2024 · EaseVRx, a software-based virtual reality (VR) medical device, is intended to offer users a prescription pain management tool that manages the symptoms associated … psp cps1 rom
EaseVRx gets FDA Approval for Its Virtual Reality ... - Tech Times
WebJan 29, 2024 · UTAH (ABC4) – The Food and Drug Administration (FDA) is prompting change in the industry of chronic pain treatment. As of Nov. 16, 2024, the FDA has authorized the marketing of a prescription-use virtual reality (VR) system called EaseVRx. EaseVRx utilizes cognitive behavioral therapy (CBT) and other therapy methods to … WebDec 9, 2024 · The answer is that EaseVRx exists for medical purposes, and that companies aren’t allowed to advertise health benefits without first receiving permission from the FDA. Going through the FDA process is a tedious, expensive, and lengthy endeavor that innovators can’t easily undertake. WebOct 27, 2024 · The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to AppliedVR‘s EaseVRx, a virtual reality therapeutic, recognizing its … psp corry pa